Comment on: "The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab"

Drugs. 2024 Dec 20. doi: 10.1007/s40265-024-02139-9. Online ahead of print.

Author

Raffaele Giusti¹

Affiliation

¹ Azienda Ospedaliero Universitaria Sant'Andrea, Medical Oncology Unit, Sant'Andrea Hospital of Rome, Via di Grottarossa 1035-39, 00189, Rome, Italy. rgiusti@ospedalesantandrea.it.

PMID: 39702869
DOI: 10.1007/s40265-024-02139-9

No abstract available

Publication types

Letter
Comment